Refine
Year of publication
Document Type
- Preprint (683)
- Article (403)
- Working Paper (2)
Language
- English (1088)
Has Fulltext
- yes (1088)
Is part of the Bibliography
- no (1088)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron scattering (experiments) (11)
- Hadron-Hadron Scattering (10)
- Heavy-ion collision (6)
- Collective Flow (4)
- Elastic scattering (3)
- Heavy Quark Production (3)
- Charm physics (2)
- Collectivity (2)
- Comorbidities (2)
- Correlation (2)
- Diffraction (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Ions (2)
- Jets (2)
- Jets and Jet Substructure (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Polarization (2)
- QCD (2)
- Quark-Gluon Plasma (2)
- RHIC (2)
- Shear viscosity (2)
- ABC Transporter (1)
- ALICE detector (1)
- Active middle ear implants (1)
- Animal models (1)
- Anti-nuclei (1)
- Antigen Processing (1)
- Attention-deficit/hyperactivity disorder (1)
- Auditory system (1)
- B-slope (1)
- Behavioral tests (1)
- Biodiversity (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Cardiomyocyte signaling pathways (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Cellular Immune Response (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- ClpB (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Consensus statement (1)
- Critical point (1)
- Data management (1)
- Data sharing (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Drug targeting (1)
- EBV (1)
- ERAL1 (1)
- Ecosystems (1)
- Ed Diener (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Endothelial permeability (1)
- Environment (1)
- Epigenetics (1)
- Extracellular RNA (eRNA) (1)
- Fibre/foam sandwich radiator (1)
- Flow (1)
- Fruit fly (1)
- Gene (1)
- Genetics (1)
- Get Pathway (1)
- Groomed jet radius (1)
- HARS2 (1)
- Hadron-hadron interactions (1)
- Hadronization (1)
- Hard Scattering (1)
- Health policy (1)
- Heart regeneration (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Heavy-ion collisions (1)
- Higher moments (1)
- Induced pluripotent stem cells (1)
- Interference fragmentation function (1)
- Intracellular Trafficking (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Ischemia–reperfusion injury (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- KCGS (1)
- LARS2 (1)
- LHC (1)
- LTER (1)
- Lipid metabolism (1)
- Long‐term ecosystem research (1)
- Material budget (1)
- MicroRNAs (miRNAs) (1)
- Minimum Bias (1)
- Mitochondria (1)
- Mixed hearing loss (1)
- Monte Carlo (1)
- Mouse (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neural network (1)
- Nonflow (1)
- Observation (1)
- Parkinson’s disease (1)
- Particle and Resonance Production (1)
- Pb–Pb collisions (1)
- Production Cross Section (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric traits (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Rapidity Range (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Remote ischemic conditioning (1)
- Research infrastructure (1)
- Resolution Parameter (1)
- Rodents (1)
- STAR (1)
- Site networks (1)
- Socio-ecology (1)
- SoftDrop (1)
- Spin alignment (1)
- Splitting function (1)
- Surgery (1)
- Systematic Uncertainty (1)
- TR (1)
- TWNK (1)
- Tail-anchored Proteins (1)
- Technical data (1)
- Thermal model (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transversity (1)
- Trigger (1)
- Viral Immunology (1)
- Xenon-based gas mixture (1)
- Zebrafish (1)
- acute‐on‐chronic liver failure (1)
- alleles (1)
- antilocality (1)
- ataxia (1)
- autism spectrum disorder (1)
- autistic disorder (1)
- biogeographic legaciese (1)
- chemogenomic set (1)
- circulation (1)
- cirrhosis (1)
- color vision (1)
- contextual modulation (1)
- copy number polymorphism (1)
- dE/dx (1)
- detector (1)
- drug discovery (1)
- druggable genome (1)
- efficient coding (1)
- experimental results (1)
- focus movement (1)
- forest classification (1)
- forest functional similarity (1)
- gamma oscillations (1)
- genes (1)
- genetics (1)
- genome (1)
- genotype (1)
- genotype determination (1)
- global change (1)
- habitat destruction (1)
- happiness (1)
- heavy ion experiments (1)
- hemodynamic (1)
- inflammation (1)
- kinase inhibitor (1)
- land use (1)
- leukodystrophy (1)
- life satisfaction (1)
- neuroscience (1)
- obituary (1)
- obituary announcement (1)
- p+p collisions (1)
- phenotype (1)
- phenotypic screening (1)
- phylogenetic community distance (1)
- positive psychology (1)
- predictive coding (1)
- protein kinase (1)
- quark gluon plasma (1)
- research article (1)
- resumptive pronouns (1)
- rhesus macaque (1)
- single nucleotide polymorphism (1)
- small molecules (1)
- subject-only resumption (1)
- subjective well-being (1)
- surround suppression (1)
- tropical forests (1)
- understudied kinase (1)
Institute
- Physik (1022)
- Frankfurt Institute for Advanced Studies (FIAS) (932)
- Informatik (862)
- Medizin (15)
- Geowissenschaften (4)
- Institut für Ökologie, Evolution und Diversität (4)
- Informatik und Mathematik (3)
- Biochemie und Chemie (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Center for Financial Studies (CFS) (2)
Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.
This paper offers a description and account of the patterns of 'ex-situ' focus in Dagbani. We show that there are two syntactic strategies for creating 'ex-situ' focus in the language, one involving A’-movement to the left periphery, and the second involving base generation in the left periphery combined with coreference to a resumptive pronoun. Furthermore, we argue that subjects are difficult to move from Spec,TP to Spec,CP in the left-periphery because of 'anti-locality', which creates a tension when trying to focus subjects, which are required to derivationally fill the specifier of both positions. We further show that what looks to be a two-way distinction between the behaviour of subjects and non-subjects in the language is in fact a three-way distinction between subjects that are focussed to a local left-periphery, subjects that are focussed to a non-local left-periphery, and non-subjects. These distinctions arise due to there being two methods for Dagbani to resolve the antilocality problem of subject movement, and so local subjects solve the problem differently to non-local subjects.
Global change effects on biodiversity and human wellbeing call for improved long-term environmental data as a basis for science, policy and decision making, including increased interoperability, multifunctionality, and harmonization. Based on the example of two global initiatives, the International Long-Term Ecological Research (ILTER) network and the Group on Earth Observations Biodiversity Observation Network (GEO BON), we propose merging the frameworks behind these initiatives, namely ecosystem integrity and essential biodiversity variables, to serve as an improved guideline for future site-based long-term research and monitoring in terrestrial, freshwater and coastal ecosystems. We derive a list of specific recommendations of what and how to measure at a monitoring site and call for an integration of sites into co-located site networks across individual monitoring initiatives, and centered on ecosystems. This facilitates the generation of linked comprehensive ecosystem monitoring data, supports synergies in the use of costly infrastructures, fosters cross-initiative research and provides a template for collaboration beyond the ILTER and GEO BON communities.
Since its founding in 1993 the International Long-term Ecological Research Network (ILTER) has gone through pronounced development phases. The current network comprises 44 active member LTER networks representing 700 LTER Sites and ~ 80 LTSER Platforms across all continents, active in the fields of ecosystem, critical zone and socio-ecological research. The critical challenges and most important achievements of the initial phase have now become state-of-the-art in networking for excellent science. At the same time increasing integration, accelerating technology, networking of resources and a strong pull for more socially relevant scientific information have been modifying the mission and goals of ILTER. This article provides a critical review of ILTER's mission, goals, development and impacts. Major characteristics, tools, services, partnerships and selected examples of relative strengths relevant for advancing ILTER are presented. We elaborate on the tradeoffs between the needs of the scientific community and stakeholder expectations. The embedding of ILTER in an increasingly collaborative landscape of global environmental observation and ecological research networks and infrastructures is also reflected by developments of pioneering regional and national LTER networks such as SAEON in South Africa, CERN/CEOBEX in China, TERN in Australia or eLTER RI in Europe. The primary role of ILTER is currently seen as a mechanism to investigate ecosystem structure, function, and services in response to a wide range of environmental forcings using long-term, place-based research. We suggest four main fields of activities and advancements for the next decade through development/delivery of a: (1) Global multi-disciplinary community of researchers and research institutes; (2) Strategic global framework and strong partnerships in ecosystem observation and research; (3) Global Research Infrastructure (GRI); and (4) a scientific knowledge factory for societally relevant information on sustainable use of natural resources.
Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.
Background & Aims: Acute‐on‐chronic liver failure (ACLF) is characterized by high short‐term mortality and systemic inflammation (SI). Recently, different cardiodynamic states were shown to independently predict outcomes in cirrhosis. The relationship between cardiodynamic states, SI, and portal hypertension and their impact on ACLF development remains unclear. The aim of this study was therefore to evaluate the interplay of cardiodynamic state and SI on fatal ACLF development in cirrhosis.
Results: At inclusion, hemodynamic measures including cardiac index (CI) and hepatic venous pressure gradient of 208 patients were measured. Patients were followed prospectively for fatal ACLF development (primary endpoint). SI was assessed by proinflammatory markers such as interleukins (ILs) 6 and 8 and soluble IL‐33 receptor (sIL‐33R). Patients were divided according to CI (<3.2; 3.2‐4.2; >4.2 L/min/m2) in hypo‐ (n = 84), normo‐ (n = 69) and hyperdynamic group (n = 55). After a median follow‐up of 3 years, the highest risk of fatal ACLF was seen in hyperdynamic (35%) and hypodynamic patients (25%) compared with normodynamic (14%) (P = .011). Hyperdynamic patients showed the highest rate of SI. The detectable level of IL‐6 was an independent predictor of fatal ACLF development.
Conclusions: Cirrhotic patients with hyperdynamic and hypodynamic circulation have a higher risk of fatal ACLF. Therefore, the cardiodynamic state is strongly associated with SI, which is an independent predictor of development of fatal ACLF.
In memory of Edward Diener: reflections on his career, contributions and the science of happiness
(2021)
Prof. Edward (Ed) Diener (1946-2021), a pioneer in positive psychology, passed away on the 27th of April 2021 at his home in Salt Lake City, Utah (Salt Lake City Tribune, 2021). As one of the most influential psychologists of the discipline, Ed Diener pushed the boundaries of our understanding of positive psychological functioning, subjective well-being, and happiness (Layous, 2020). As one of the Top 200 most cited researchers across all disciplines and fields, he will be most remembered for founding the scientific study of subjective well-being (SWB) and happiness (Bakshi, 2019). Diener developed the concept of subjective well-being by exploring the factors that influence people's life satisfaction (Diener et al., 2017a). He studied the individual causes of subjective well-being, such as close social relationships, income, meaning and purpose, personality, and societal causes, such as economic development, low corruption and crime, and a healthy environment (Diener et al., 2018). His research has discovered both universal and culture-specific causes and consequences of SWB and influenced governmental policy (Oishi et al., 1999). In respect of his memory, the purpose of this paper is threefold: (a) to reflect upon his career journey, (b) to celebrate his significant contributions to the discipline, and (c) to provide personal reflections of those who worked closely with him over the past 50 years.
Biodiversity continues to decline in the face of increasing anthropogenic pressures such as habitat destruction, exploitation, pollution and introduction of alien species. Existing global databases of species’ threat status or population time series are dominated by charismatic species. The collation of datasets with broad taxonomic and biogeographic extents, and that support computation of a range of biodiversity indicators, is necessary to enable better understanding of historical declines and to project – and avert – future declines. We describe and assess a new database of more than 1.6 million samples from 78 countries representing over 28,000 species, collated from existing spatial comparisons of local-scale biodiversity exposed to different intensities and types of anthropogenic pressures, from terrestrial sites around the world. The database contains measurements taken in 208 (of 814) ecoregions, 13 (of 14) biomes, 25 (of 35) biodiversity hotspots and 16 (of 17) megadiverse countries. The database contains more than 1% of the total number of all species described, and more than 1% of the described species within many taxonomic groups – including flowering plants, gymnosperms, birds, mammals, reptiles, amphibians, beetles, lepidopterans and hymenopterans. The dataset, which is still being added to, is therefore already considerably larger and more representative than those used by previous quantitative models of biodiversity trends and responses. The database is being assembled as part of the PREDICTS project (Projecting Responses of Ecological Diversity In Changing Terrestrial Systems – www.predicts.org.uk). We make site-level summary data available alongside this article. The full database will be publicly available in 2015.
Highlights
• Overview on functional work performed in rodent, zebrafish and fruit fly models of ADHD and its comorbidities.
• Comprehensive search for new genetically modified mouse models to study ADHD-related and comorbid traits.
• Review of behavioral assays available in animal models to test ADHD-related and comorbid traits.
• Animal models to assess environmental effects contributing to the epigenetic mechanisms of ADHD and comorbidities.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder resulting from the interaction between genetic and environmental risk factors. It is well known that ADHD co-occurs frequently with other psychiatric disorders due, in part, to shared genetics factors. Although many studies have contributed to delineate the genetic landscape of psychiatric disorders, their specific molecular underpinnings are still not fully understood. The use of animal models can help us to understand the role of specific genes and environmental stimuli-induced epigenetic modifications in the pathogenesis of ADHD and its comorbidities. The aim of this review is to provide an overview on the functional work performed in rodents, zebrafish and fruit fly and highlight the generated insights into the biology of ADHD, with a special focus on genetics and epigenetics. We also describe the behavioral tests that are available to study ADHD-relevant phenotypes and comorbid traits in these models. Furthermore, we have searched for new models to study ADHD and its comorbidities, which can be useful to test potential pharmacological treatments.